AMOXICILLIN AND CLAVULANIC ACID IN THE TREATMENT OF ACTINOMYCETOMA
- 1 March 1993
- journal article
- case report
- Published by Wiley in International Journal of Dermatology
- Vol. 32 (3) , 218-220
- https://doi.org/10.1111/j.1365-4362.1993.tb02800.x
Abstract
Mycetoma is a relatively frequent disease in tropical countries. Drugs commonly used need a long period of treatment, and some cases are resistant to these drugs, especially those with bone or visceral involvement. The combination of amoxicillin-clavulanic acid has shown effectiveness against strains of Nocardia brasiliensis in vitro.We have used this combination in two cases of mycetoma caused by N. brasiliensis, both with bone involvement and resistance to the drugs usually used. A dose of three tablets a day for 5 to 6 months was given (each tablet contains 500 mg of amoxicillin and 125 mg of clavulanic acid).Clinical and mycologic amelioration was observed in the two cases after completing the treatment. There were no side effects or relapses after 3 to 6 months of follow-up after treatment.We propose this antibiotic as a new option for the treatment of some special cases of actinomycetoma with bone or visceral involvement or resistance to the drugs commonly used in this disease.Keywords
This publication has 5 references indexed in Scilit:
- MycetomaInternational Journal of Dermatology, 1991
- \gb-Lactam Resistance in Nocardia brasiliensis is Mediated by -Lactamase and Reversed in the Presence of Clavulanic AcidThe Journal of Infectious Diseases, 1987
- Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetomaJournal of the American Academy of Dermatology, 1987
- MycetomaInternational Journal of Dermatology, 1984
- Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerusAntimicrobial Agents and Chemotherapy, 1977